ReviewCurrent gastroenterology reports2025
Digital and Conventional Behavioral Therapies for Neurogastroenterology and Motility Disorders.
Review in Current gastroenterology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewBrain-gut behavior therapies (BGBTs) comprise of several behavioral and psychological therapies such as cognitive-behavioral therapy or gut-directed hypnotherapy that are effective at improving symptom management and quality of life for patients with a range of neurogastroenterology and motility disorders. This review highlights recent advances in BGBT approaches, including novel delivery methods to improve access to care. RECENT
findingsTraditional BGBT approaches have evolved to more effectively target GI-specific psychological processes, with exposure techniques and mindfulness-based skills emerging as important elements of treatment. BGBTs are also being delivered in new ways, including digital formats, to expand access to care. Digital therapeutics show promise; however, feasibility of these tools in clinical practice remains unclear. BGBTs continue to evolve to address the complex needs of patients with Disorders of Gut-Brain Interaction (DGBI) and are being applied more broadly to treat the full spectrum of DGBI conditions. Novel delivery methods show promise; however, further research is needed to identify real-world effectiveness of digital treatments and to identify patients most likely to benefit.
Indexed as
Identifiers
40759797What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.